摘要
2017年国家卫生健康委员会发布《原发性肝癌诊疗指南》第1版,2019年、2022年先后2次发布修订版。近期国家卫生健康委员会再次更新指南,发布《原发性肝癌诊疗指南(2024年版)》。该指南旨在早期诊断、早期治疗原发性肝癌及提高原发性肝癌患者的生存率。影像诊断在原发性肝癌早期诊断中具有极为重要的作用,2024新版指南影像诊断方面的重要更新为亚厘米肝癌(直径≤1.0 cm)的早期影像诊断。本文将着重对亚厘米肝癌早期诊断方面的更新进行解读。
Since the publication of guidelines for diagnosis and treatment of primary liver cancer by National Health Commission of the People's Republic of China in 2017,which were updated in 2019 and 2022.The new version of the guidelines(2024 edition)has been published,which aims to early diagnosis,treatment and improvement of survival rate for patients with hepatocellular carcinoma.Imaging is essential for early diagnosis of hepatocellular carcinoma and the new guidelines feature major changes in the imaging techniques for early diagnosis of subcentimeter hepatocellular carcinoma(diameter≤1.0 cm),which were interpretated in this article.
作者
饶圣祥
张岚
RAO Shengxiang;ZHANG Lan(Department of Radiology,Zhongshan Hospital,Fudan University,Shanghai 200032,China)
出处
《中国医学影像学杂志》
CSCD
北大核心
2024年第6期529-532,共4页
Chinese Journal of Medical Imaging
关键词
癌
肝细胞
磁共振成像
扩散加权成像
钆塞酸二钠
诊断
指南
解读
Carcinoma,hepatocellular
Magnetic resonance imaging
Diffusion-weighted imaging
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid
Diagnosis
Guide
Interpretation
